DNA repair capacity is impaired in healthy BRCA1 heterozygous mutation carriers

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2015-06-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-015-3459-3PMID 26071757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic instability in lymphoblastoid cell lines expressing biallelic and monoallelic variants in the human MUTYH gene.

  2014cited by this paper
• BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development

  2014cited by this paper
• Heterozygous mutations in PALB2 cause DNA replication and damage response defects

  2013cited by this paper
• miRNA dysregulation in breast cancer.

  2013cited by this paper
• A high-throughput functional complementation assay for classification of BRCA1 missense variants.

  2013cited by this paper
• Determination of Molecular Markers for BRCA1 and BRCA2 Heterozygosity Using Gene Expression Profiling

  2013cited by this paper
• Loss of PPARγ expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment

  2013cited by this paper
• The Influence of BRCA1/BRCA2 Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients

  2013cited by this paper
• Stromal adipocyte PPARγ protects against breast tumorigenesis.

  2012cited by this paper
• BRCA1 and BRCA2: different roles in a common pathway of genome protection

  2011cited by this paper
• A novel role for BRCA1 in regulating breast cancer cell spreading and motility

  2011cited by this paper
• BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

  2011cited by this paper
• Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis

  2011cited by this paper
• Altered Gene Expression in Morphologically Normal Epithelial Cells from Heterozygous Carriers of BRCA1 or BRCA2 Mutations

  2010cited by this paper
• The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding

  2010cited by this paper
• Does the nonsense‐mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins?

  2008cited by this paper
• BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression

  2008cited by this paper
• The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.

  2008cited by this paper
• BRCA1 Haploinsufficiency, but not Heterozygosity for a BRCA1-truncating Mutation, Deregulates Homologous Recombination

  2007cited by this paper
• The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon

  2006cited by this paper
• Characterization of BRCA1 and BRCA2 mutations in a large United States sample.

  2006cited by this paper
• Accurate Prediction of BRCA1 and BRCA2 Heterozygous Genotype Using Expression Profiling after Induced DNA Damage

  2006cited by this paper
• The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair

  2005cited by this paper
• Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species.

  2005cited by this paper
• Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants

  2005cited by this paper
• Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells

  2004cited by this paper
• Gene Expression Profiling after Radiation-Induced DNA Damage Is Strongly Predictive of BRCA1 Mutation Carrier Status

  2004cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Cell Cycle Differences in DNA Damage-induced BRCA1 Phosphorylation Affect Its Subcellular Localization*

  2003cited by this paper
• Variation in BRCA1 cancer risks by mutation position.

  2002cited by this paper
• The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.

  2002cited by this paper
• Dominant-negative activity of a Brca1 truncation mutant: effects on proliferation, tumorigenicity in vivo, and chemosensitivity in a mouse ovarian cancer cell line.

  2002cited by this paper
• Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1

  2001cited by this paper
• Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage.

  1997cited by this paper
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

  1995cited by this paper
• Mutation and cancer: statistical study of retinoblastoma.

  1971cited by this paper

• Mutational profiles of spontaneous and radiation-related mammary carcinomas in a rat model of Brca1 haploinsufficiency.

  2026cites this paper
• Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

  2025cites this paper
• BRCA1 protein dose-dependent risk for embryonic oxidative DNA damage, embryopathies and neurodevelopmental disorders with and without ethanol exposure

  2024cites this paper
• Comprehensive Analysis of Regulatory Factors and Immune-Associated Patterns to Decipher Common and BRCA1/2 Mutation-Type-Specific Critical Regulation in Breast Cancer

  2021cites this paper
• Assessing BRCA1 activity in DNA damage repair using human induced pluripotent stem cells as an approach to assist classification of BRCA1 variants of uncertain significance

  2021cites this paper
• Genetic and epigenetic profiling of the BRCA1 / 2 genes in solitary ovarian cancer and multiple primary ovarian tumors

  2021cites this paper
• Novel mechanisms in alcohol neurodevelopmental disorders via BRCA1 depletion and BRCA1-dependent NADPH oxidase regulation

  2021cites this paper
• 2-hexyl-4-pentynoic acid (HPTA), a novel radiosensitizer to breast cancer cells through increasing the instability of DNA repair proteins

  2020cites this paper
• Decreased DNA double‑strand break repair and enhanced chromosomal radiosensitivity in irradiated non‑tumorigenic human breast epithelial cells with a partial BRCA1 or BRCA2 knockdown

  2020cites this paper
• Western Analysis of Breast Cancer 1 Protein (BRCA1).

  2019cites this paper
• BRCA1 mislocalization leads to aberrant DNA damage response in heterozygous ABRAXAS1 mutation carrier cells.

  2019cites this paper
• Oxidative stress and DNA damage in the mechanism of fetal alcohol spectrum disorders

  2019cites this paper
• A common SNP in the UNG gene decreases ovarian cancer risk in BRCA2 mutation carriers

  2019cites this paper
• A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?

  2018cites this paper
• Altered expression of telomere‐associated genes in leukocytes among BRCA1 and BRCA2 carriers

  2018cites this paper
• Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes

  2017cites this paper
• The fate of BRCA1-related germline mutations in triple-negative breast tumors.

  2017cites this paper
• BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer

  2017cites this paper
• Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families

  2017cites this paper
• Genetic variation in the NEIL2 DNA glycosylase gene is associated with oxidative DNA damage in BRCA2 mutation carriers

  2017cites this paper
• Accurate quantification of homologous recombination in zebrafish: brca2 deficiency as a paradigm

  2017cites this paper
• Valproic acid causes radiosensitivity of breast cancer cells via disrupting the DNA repair pathway.

  2016cites this paper
• Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation

  2016cites this paper
• Fetal oxidative stress mechanisms of neurodevelopmental deficits and exacerbation by ethanol and methamphetamine.

  2016cites this paper
• Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific

  2016cites this paper
• STRUCTURAL BIOLOGY AND BIOCOMPUTING PROGRAMME

  2016cites this paper
• Defects in homologous recombination repair behind the human diseases: FA and HBOC.

  2016cites this paper
• Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers

  2016cites this paper
• Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect.

  2016cites this paper